Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 125

1.

Results and conclusions of the European Intergroup EURO-LB02 trial in children and adolescents with lymphoblastic lymphoma.

Landmann E, Burkhardt B, Zimmermann M, Meyer U, Woessmann W, Klapper W, Wrobel G, Rosolen A, Pillon M, Escherich G, Attarbaschi A, Beishuizen A, Mellgren K, Wynn R, Ratei R, Plesa A, Schrappe M, Reiter A, Bergeron C, Patte C, Bertrand Y.

Haematologica. 2017 Dec;102(12):2086-2096. doi: 10.3324/haematol.2015.139162. Epub 2017 Oct 5.

2.

Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.

Tombolan L, Poli E, Martini P, Zin A, Millino C, Pacchioni B, Celegato B, Bisogno G, Romualdi C, Rosolen A, Lanfranchi G.

BMC Cancer. 2016 Nov 14;16(1):886.

3.

Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead.

Minard-Colin V, Brugières L, Reiter A, Cairo MS, Gross TG, Woessmann W, Burkhardt B, Sandlund JT, Williams D, Pillon M, Horibe K, Auperin A, Le Deley MC, Zimmerman M, Perkins SL, Raphael M, Lamant L, Klapper W, Mussolin L, Poirel HA, Macintyre E, Damm-Welk C, Rosolen A, Patte C.

J Clin Oncol. 2015 Sep 20;33(27):2963-74. doi: 10.1200/JCO.2014.59.5827. Epub 2015 Aug 24. Review.

4.

Ultrasound detection of pneumonia in febrile children with respiratory distress: a prospective study.

Guerra M, Crichiutti G, Pecile P, Romanello C, Busolini E, Valent F, Rosolen A.

Eur J Pediatr. 2016 Feb;175(2):163-70. doi: 10.1007/s00431-015-2611-8. Epub 2015 Aug 19.

PMID:
26283293
5.

Non-Hodgkin lymphoma in children with an associated inherited condition: A retrospective analysis of the Associazione Italiana Ematologia Oncologia Pediatrica (AIEOP).

Aricò M, Mussolin L, Carraro E, Buffardi S, Santoro N, D'Angelo P, Lombardi A, Pierani P, Giraldi E, Mura R, Sala A, Garaventa A, Tondo A, Piglione M, Lo Nigro L, Cesaro S, Perruccio K, Rosolen A, Basso G, Pillon M; NHL-Committee of the Italian Association of Pediatric Hematology Oncology.

Pediatr Blood Cancer. 2015 Oct;62(10):1782-9. doi: 10.1002/pbc.25565. Epub 2015 May 22.

PMID:
26011068
6.

International Pediatric Non-Hodgkin Lymphoma Response Criteria.

Sandlund JT, Guillerman RP, Perkins SL, Pinkerton CR, Rosolen A, Patte C, Reiter A, Cairo MS.

J Clin Oncol. 2015 Jun 20;33(18):2106-11. doi: 10.1200/JCO.2014.59.0745. Epub 2015 May 4.

7.

Revised International Pediatric Non-Hodgkin Lymphoma Staging System.

Rosolen A, Perkins SL, Pinkerton CR, Guillerman RP, Sandlund JT, Patte C, Reiter A, Cairo MS.

J Clin Oncol. 2015 Jun 20;33(18):2112-8. doi: 10.1200/JCO.2014.59.7203. Epub 2015 May 4.

8.

MicroRNA-27a Contributes to Rhabdomyosarcoma Cell Proliferation by Suppressing RARA and RXRA.

Tombolan L, Zampini M, Casara S, Boldrin E, Zin A, Bisogno G, Rosolen A, De Pittà C, Lanfranchi G.

PLoS One. 2015 Apr 27;10(4):e0125171. doi: 10.1371/journal.pone.0125171. eCollection 2015.

9.

ALK kinase domain mutations in primary anaplastic large cell lymphoma: consequences on NPM-ALK activity and sensitivity to tyrosine kinase inhibitors.

Lovisa F, Cozza G, Cristiani A, Cuzzolin A, Albiero A, Mussolin L, Pillon M, Moro S, Basso G, Rosolen A, Bonvini P.

PLoS One. 2015 Apr 13;10(4):e0121378. doi: 10.1371/journal.pone.0121378. eCollection 2015.

10.

Long-term results of the AIEOP LNH-97 protocol for childhood lymphoblastic lymphoma.

Pillon M, Aricò M, Mussolin L, Carraro E, Conter V, Sala A, Buffardi S, Garaventa A, D'Angelo P, Lo Nigro L, Santoro N, Piglione M, Lombardi A, Porta F, Cesaro S, Moleti ML, Casale F, Mura R, d'Amore ES, Basso G, Rosolen A.

Pediatr Blood Cancer. 2015 Aug;62(8):1388-94. doi: 10.1002/pbc.25469. Epub 2015 Mar 8.

PMID:
25755200
11.

Mediastinal Burkitt lymphoma in childhood.

Pillon M, Aricò M, Mussolin L, Mainardi C, Giraldi E, Garaventa A, Lombardi A, Santoro N, Carraro E, d'Amore ES, Rosolen A; Italian Association of Pediatric Hematology, Oncology AIEOP Non-Hodgkin Lymphoma Working Group.

Pediatr Blood Cancer. 2014 Nov;61(11):2127-8. doi: 10.1002/pbc.25127. Epub 2014 Jul 22. No abstract available.

PMID:
25053233
12.

MicroRNA 28 controls cell proliferation and is down-regulated in B-cell lymphomas.

Schneider C, Setty M, Holmes AB, Maute RL, Leslie CS, Mussolin L, Rosolen A, Dalla-Favera R, Basso K.

Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):8185-90. doi: 10.1073/pnas.1322466111. Epub 2014 May 19.

13.

Hyper-activation of Notch3 amplifies the proliferative potential of rhabdomyosarcoma cells.

De Salvo M, Raimondi L, Vella S, Adesso L, Ciarapica R, Verginelli F, Pannuti A, Citti A, Boldrini R, Milano GM, Cacchione A, Ferrari A, Collini P, Rosolen A, Bisogno G, Alaggio R, Inserra A, Locatelli M, Stifani S, Screpanti I, Miele L, Locatelli F, Rota R.

PLoS One. 2014 May 5;9(5):e96238. doi: 10.1371/journal.pone.0096238. eCollection 2014.

14.

An aberrant microRNA signature in childhood T-cell lymphoblastic lymphoma affecting CDKN1B expression, NOTCH1 and growth factor signaling pathways.

Mussolin L, Holmes AB, Romualdi C, Sales G, D'Amore ES, Ghisi M, Pillon M, Rosolen A, Basso K.

Leukemia. 2014 Sep;28(9):1909-12. doi: 10.1038/leu.2014.134. Epub 2014 Apr 14. No abstract available.

PMID:
24727675
15.

Epithelioid rhabdomyosarcoma: a clinicopathologic and molecular study.

Zin A, Bertorelle R, Dall'Igna P, Manzitti C, Gambini C, Bisogno G, Rosolen A, Alaggio R.

Am J Surg Pathol. 2014 Feb;38(2):273-8. doi: 10.1097/PAS.0000000000000105.

PMID:
24418861
16.

Monoallelic mutations of the perforin gene may represent a predisposing factor to childhood anaplastic large cell lymphoma.

Ciambotti B, Mussolin L, d'Amore ES, Pillon M, Sieni E, Coniglio ML, Ros MD, Cetica V, Aricò M, Rosolen A.

J Pediatr Hematol Oncol. 2014 Aug;36(6):e359-65. doi: 10.1097/MPH.0000000000000073.

PMID:
24309606
17.

Early assessment of minimal residual disease identifies patients at very high relapse risk in NPM-ALK-positive anaplastic large-cell lymphoma.

Damm-Welk C, Mussolin L, Zimmermann M, Pillon M, Klapper W, Oschlies I, d'Amore ES, Reiter A, Woessmann W, Rosolen A.

Blood. 2014 Jan 16;123(3):334-7. doi: 10.1182/blood-2013-09-526202. Epub 2013 Dec 2.

PMID:
24297868
18.

The Polycomb group (PcG) protein EZH2 supports the survival of PAX3-FOXO1 alveolar rhabdomyosarcoma by repressing FBXO32 (Atrogin1/MAFbx).

Ciarapica R, De Salvo M, Carcarino E, Bracaglia G, Adesso L, Leoncini PP, Dall'Agnese A, Walters ZS, Verginelli F, De Sio L, Boldrini R, Inserra A, Bisogno G, Rosolen A, Alaggio R, Ferrari A, Collini P, Locatelli M, Stifani S, Screpanti I, Rutella S, Yu Q, Marquez VE, Shipley J, Valente S, Mai A, Miele L, Puri PL, Locatelli F, Palacios D, Rota R.

Oncogene. 2014 Aug 7;33(32):4173-84. doi: 10.1038/onc.2013.471. Epub 2013 Nov 11.

PMID:
24213577
19.

High ALK mRNA expression has a negative prognostic significance in rhabdomyosarcoma.

Bonvini P, Zin A, Alaggio R, Pawel B, Bisogno G, Rosolen A.

Br J Cancer. 2013 Dec 10;109(12):3084-91. doi: 10.1038/bjc.2013.653. Epub 2013 Oct 22.

20.

Central nervous system involvement in anaplastic large cell lymphoma in childhood: results from a multicentre European and Japanese study.

Williams D, Mori T, Reiter A, Woessman W, Rosolen A, Wrobel G, Zsiros J, Uyttebroeck A, Marky I, Le Deley MC, Brugières L; European Intergroup for Childhood Non-Hodgkin Lymphoma, the Japanese Pediatric Leukemia/Lymphoma Study Group.

Pediatr Blood Cancer. 2013 Oct;60(10):E118-21. doi: 10.1002/pbc.24591. Epub 2013 May 29.

PMID:
23720354
21.

Plasma cell-free DNA in paediatric lymphomas.

Mussolin L, Burnelli R, Pillon M, Carraro E, Farruggia P, Todesco A, Mascarin M, Rosolen A.

J Cancer. 2013 Apr 16;4(4):323-9. doi: 10.7150/jca.6226. Print 2013.

22.

Children and adolescents with follicular lymphoma have an excellent prognosis with either limited chemotherapy or with a "Watch and wait" strategy after complete resection.

Attarbaschi A, Beishuizen A, Mann G, Rosolen A, Mori T, Uyttebroeck A, Niggli F, Csoka M, Krenova Z, Mellgren K, Kabickova E, Chiang AK, Reiter A, Williams D, Burkhardt B; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) and the international Berlin-Frankfurt-Münster (i-BFM) Study Group.

Ann Hematol. 2013 Nov;92(11):1537-41. doi: 10.1007/s00277-013-1785-2. Epub 2013 May 12.

PMID:
23665980
23.

Use of minimal disseminated disease and immunity to NPM-ALK antigen to stratify ALK-positive ALCL patients with different prognosis.

Mussolin L, Damm-Welk C, Pillon M, Zimmermann M, Franceschetto G, Pulford K, Reiter A, Rosolen A, Woessmann W.

Leukemia. 2013 Feb;27(2):416-22. doi: 10.1038/leu.2012.205. Epub 2012 Jul 18.

PMID:
22907048
24.

Psychosocial life achievements in adults even if they received prophylactic cranial irradiation for acute lymphoblastic leukemia during childhood.

Pillon M, Tridello G, Boaro MP, Messina C, Putti MC, Varotto S, Petris MG, Scrimin S, Zanesco L, Rosolen A, Basso G.

Leuk Lymphoma. 2013 Feb;54(2):315-20. doi: 10.3109/10428194.2012.710903. Epub 2012 Sep 8.

PMID:
22793040
25.

Effect of inhibition of the ubiquitin-proteasome system and Hsp90 on growth and survival of rhabdomyosarcoma cells in vitro.

Peron M, Bonvini P, Rosolen A.

BMC Cancer. 2012 Jun 12;12:233. doi: 10.1186/1471-2407-12-233.

26.

Expression of multidrug resistance-associated proteins in paediatric soft tissue sarcomas before and after chemotherapy.

Citti A, Boldrini R, Inserra A, Alisi A, Pessolano R, Mastronuzzi A, Zin A, De Sio L, Rosolen A, Locatelli F, Fruci D.

Int J Oncol. 2012 Jul;41(1):117-24. doi: 10.3892/ijo.2012.1433. Epub 2012 Apr 10.

PMID:
22504834
27.

Results of AIEOP LNH-97 protocol for the treatment of anaplastic large cell lymphoma of childhood.

Pillon M, Gregucci F, Lombardi A, Santoro N, Piglione M, Sala A, D'Amore ES, De Santis R, Casale F, Zecca M, Mussolin L, Rosolen A; NHL-Committee of the Italian Association of Pediatric Hematology and Oncology (AIEOP).

Pediatr Blood Cancer. 2012 Nov;59(5):828-33. doi: 10.1002/pbc.24125. Epub 2012 Mar 2.

PMID:
22389307
28.

Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30+ NPM-ALK+ anaplastic large-cell lymphomas.

Bonvini P, Zorzi E, Mussolin L, Pillon M, Romualdi C, Peron M, d'Amore ES, Lamant L, Rosolen A.

Leukemia. 2012 Jun;26(6):1375-82. doi: 10.1038/leu.2011.367. Epub 2012 Jan 6.

PMID:
22289917
29.

Treatment of pharyngeal non-Hodgkin lymphoma in a patient with Wiskott-Aldrich syndrome.

Coccia P, Mastrangelo S, Ruggiero A, Scalzone M, Rosolen A, Maurizi P, Riccardi R.

Pediatr Blood Cancer. 2012 Aug;59(2):318-9. doi: 10.1002/pbc.23393. Epub 2011 Nov 2.

PMID:
22052860
30.

T-cell lymphoblastic lymphoma shows differences and similarities with T-cell acute lymphoblastic leukemia by genomic and gene expression analyses.

Basso K, Mussolin L, Lettieri A, Brahmachary M, Lim WK, Califano A, Basso G, Biondi A, Cazzaniga G, Rosolen A.

Genes Chromosomes Cancer. 2011 Dec;50(12):1063-75. doi: 10.1002/gcc.20924. Epub 2011 Aug 30.

PMID:
21987448
31.

Urolithin as a converging scaffold linking ellagic acid and coumarin analogues: design of potent protein kinase CK2 inhibitors.

Cozza G, Gianoncelli A, Bonvini P, Zorzi E, Pasquale R, Rosolen A, Pinna LA, Meggio F, Zagotto G, Moro S.

ChemMedChem. 2011 Dec 9;6(12):2273-86. doi: 10.1002/cmdc.201100338. Epub 2011 Oct 4.

PMID:
21972104
32.

High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma.

Tombolan L, Orso F, Guzzardo V, Casara S, Zin A, Bonora M, Romualdi C, Giorgi C, Bisogno G, Alaggio R, Pinton P, De Pittà C, Taverna D, Rosolen A, Lanfranchi G.

Am J Pathol. 2011 Nov;179(5):2611-24. doi: 10.1016/j.ajpath.2011.07.018. Epub 2011 Sep 13.

33.

Limited stage I disease is not necessarily indicative of an excellent prognosis in childhood anaplastic large cell lymphoma.

Attarbaschi A, Mann G, Rosolen A, Williams D, Uyttebroeck A, Marky I, Lamant L, Horibe K, Wrobel G, Beishuizen A, Wössmann W, Reiter A, Mauguen A, Le Deley MC, Brugières L; European Intergroup for Childhood Non-Hodgkin Lymphoma (EICNHL) ALCL99 Trial.

Blood. 2011 May 26;117(21):5616-9. doi: 10.1182/blood-2010-12-324012. Epub 2011 Mar 28.

PMID:
21444917
34.

A case of resistant pediatric histiocytic sarcoma successfully treated with chemo-radiotherapy and autologous peripheral blood stem cell transplant.

Mainardi C, D'Amore ES, Pillon M, Toffolutti T, Rosolen A.

Leuk Lymphoma. 2011 Jul;52(7):1367-71. doi: 10.3109/10428194.2011.565840. Epub 2011 Mar 22. Review. No abstract available.

PMID:
21425962
35.

Minimal disseminated disease in high-risk Burkitt's lymphoma identifies patients with different prognosis.

Mussolin L, Pillon M, d'Amore ES, Conter V, Piglione M, Lo Nigro L, Garaventa A, Buffardi S, Aricò M, Rosolen A.

J Clin Oncol. 2011 May 1;29(13):1779-84. doi: 10.1200/JCO.2010.32.8161. Epub 2011 Mar 21. Erratum in: J Clin Oncol. 2015 Jun 10;33(17):1991.

PMID:
21422413
36.

Long-term results of AIEOP-8805 protocol for acute B-cell lymphoblastic leukemia of childhood.

Pillon M, Aricò M, Basso G, Locatelli F, Citterio M, Micalizzi C, Testi AM, Barisone E, Nardi M, Lombardi A, Rondelli R, Rosolen A; NHL-Committee of the Italian Association of Pediatric Hematology, Oncology.

Pediatr Blood Cancer. 2011 Apr;56(4):544-50. doi: 10.1002/pbc.22787. Epub 2010 Dec 15.

PMID:
21298738
37.

Safety assessment of intensive induction therapy in childhood anaplastic large cell lymphoma: report of the ALCL99 randomised trial.

Wrobel G, Mauguen A, Rosolen A, Reiter A, Williams D, Horibe K, Brugières L, Le Deley MC; European Inter-Group for Childhood, Non-Hodgkin Lymphoma (EICNHL).

Pediatr Blood Cancer. 2011 Jul 1;56(7):1071-7. doi: 10.1002/pbc.22940. Epub 2011 Jan 28.

PMID:
21280197
38.

Clinical, pathological and genetic features of primary mediastinal large B-cell lymphomas and mediastinal gray zone lymphomas in children.

Oschlies I, Burkhardt B, Salaverria I, Rosenwald A, d'Amore ES, Szczepanowski M, Koch K, Hansmann ML, Stein H, Möller P, Reiter A, Zimmermann M, Rosolen A, Siebert R, Jaffe ES, Klapper W.

Haematologica. 2011 Feb;96(2):262-8. doi: 10.3324/haematol.2010.030809. Epub 2010 Oct 22.

39.

Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.

Le Deley MC, Rosolen A, Williams DM, Horibe K, Wrobel G, Attarbaschi A, Zsiros J, Uyttebroeck A, Marky IM, Lamant L, Woessmann W, Pillon M, Hobson R, Mauguen A, Reiter A, Brugières L.

J Clin Oncol. 2010 Sep 1;28(25):3987-93. doi: 10.1200/JCO.2010.28.5999. Epub 2010 Aug 2.

PMID:
20679620
40.

Cytogenetic analysis of pediatric anaplastic large cell lymphoma.

Mussolin L, Pillon M, Bonato P, Leszl A, Franceschetto G, Di Meglio A, d'Amore ES, Sainati L, Rosolen A.

Pediatr Blood Cancer. 2010 Sep;55(3):446-51. doi: 10.1002/pbc.22550.

PMID:
20658615
41.

New miRNA labeling method for bead-based quantification.

Biscontin A, Casara S, Cagnin S, Tombolan L, Rosolen A, Lanfranchi G, De Pittà C.

BMC Mol Biol. 2010 Jun 16;11:44. doi: 10.1186/1471-2199-11-44.

42.

Sequential intensified chemotherapy with stem cell rescue for children and adolescents with desmoplastic small round-cell tumor.

Bisogno G, Ferrari A, Rosolen A, Alaggio R, Scarzello G, Garaventa A, Arcamone G, Carli M.

Bone Marrow Transplant. 2010 May;45(5):907-11. doi: 10.1038/bmt.2009.248. Epub 2009 Oct 5.

PMID:
19802018
43.

Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion.

Masola V, Maran C, Tassone E, Zin A, Rosolen A, Onisto M.

BMC Cancer. 2009 Aug 28;9:304. doi: 10.1186/1471-2407-9-304.

44.

IGH and IGK gene rearrangements as PCR targets for pediatric Burkitt's lymphoma and mature B-ALL MRD analysis.

Lovisa F, Mussolin L, Corral L, Pillon M, Cazzaniga G, Biondi A, Rosolen A.

Lab Invest. 2009 Oct;89(10):1182-6. doi: 10.1038/labinvest.2009.81. Epub 2009 Aug 10.

45.

Long-term results of AIEOP LNH-92 protocol for the treatment of pediatric lymphoblastic lymphoma: a report of the Italian Association of Pediatric Hematology and Oncology.

Pillon M, Piglione M, Garaventa A, Conter V, Giuliano M, Arcamone G, Mura R, Cellini M, D'Amore ES, Varotto S, Mussolin L, Rosolen A; AIEOP-NHL Committee.

Pediatr Blood Cancer. 2009 Dec;53(6):953-9. doi: 10.1002/pbc.22162.

PMID:
19621432
46.

The effect of the cyclin-dependent kinase inhibitor flavopiridol on anaplastic large cell lymphoma cells and relationship with NPM-ALK kinase expression and activity.

Bonvini P, Zorzi E, Mussolin L, Monaco G, Pigazzi M, Basso G, Rosolen A.

Haematologica. 2009 Jul;94(7):944-55. doi: 10.3324/haematol.2008.004861. Epub 2009 Jun 16.

47.

Pediatric extra-renal rhabdoid tumors with unusual morphology: a diagnostic pitfall for small biopsies.

Alaggio R, Boldrini R, Di Venosa B, Rosolen A, Bisogno G, Magro G.

Pathol Res Pract. 2009;205(7):451-7. doi: 10.1016/j.prp.2009.01.003. Epub 2009 Feb 24.

PMID:
19243895
48.

Impact of the methotrexate administration dose on the need for intrathecal treatment in children and adolescents with anaplastic large-cell lymphoma: results of a randomized trial of the EICNHL Group.

Brugières L, Le Deley MC, Rosolen A, Williams D, Horibe K, Wrobel G, Mann G, Zsiros J, Uyttebroeck A, Marky I, Lamant L, Reiter A.

J Clin Oncol. 2009 Feb 20;27(6):897-903. doi: 10.1200/JCO.2008.18.1487. Epub 2009 Jan 12.

PMID:
19139435
49.

Morphologic Overlap between Infantile Myofibromatosis and Infantile Fibrosarcoma: A Pitfall in Diagnosis.

Alaggio R, Barisani D, Ninfo V, Rosolen A, Coffin CM.

Pediatr Dev Pathol. 2008 Sep-Oct;11(5):355-62. doi: 10.2350/07-09-0355.1. Epub 2008 Feb 14.

PMID:
19006426
50.

Kinetics of humoral response to ALK and its relationship with minimal residual disease in pediatric ALCL.

Mussolin L, Bonvini P, Ait-Tahar K, Pillon M, Tridello G, Buffardi S, Lombardi A, Pulford K, Rosolen A.

Leukemia. 2009 Feb;23(2):400-2. doi: 10.1038/leu.2008.184. Epub 2008 Jul 10. No abstract available.

PMID:
18615104

Supplemental Content

Loading ...
Support Center